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Type of Pneumonia 
Vitamin D Placebo 
Incidence 
Rate 












Rate 95% CI 
 
x-ray confirmed 
All Pneumonia 230 1620 0.14 0.12 - 0.16 219 1625 0.13 0.12- 0.15 1.06 0.88 – 1.27 0.54 
Simple Pneumonia 201 1650 0.12 0.11 - 0.14 195 1652 0.11 0.10  -  0.14 1.03 0.85 – 1.26 0.71 
Severe Pneumonia 44 1787 0.024 0.018 - 0.033 36 1794 0.020 0.014 - 0.028 1.23 0.79 – 1.91 0.35 
Very Severe diseases 12 1819 0.006 0.003 - 0.012 9 1815 0.005 0.002 -  0.009 1.33 0.56 – 3.17  0.51 
 
x-ray confirmed & non-confirmed 
All Pneumonia 915 910 1.01 0.94 - 1.07 922 895 1.03 0.96  -  1.09 0.98 0.89 – 1.07 0.68 
Simple Pneumonia 902 949 0.95 0.89 -  1.01 885 947 0.93 0.87 – 0.99 1.02 0.93 – 1.12 0.67 
Severe Pneumonia 148 1678 0.09 0.07 - 0.10 135 1697 0.08 0.07  -  0.09 1.11 0.88 – 1.40 0.38 
Very Severe diseases 135 1724 0.08 0.06 - 0.09 155 1704 0.09 0.07 - 0.11 0.86 0.68 – 1.08 0.21 
 






Type of Pneumonia 
Vitamin D Placebo 
Incidence 
Rate 














125 1828 0.07 0.06 - 0.08 74 1824 0.04 0.03 - 0.05 1.69 1.27 – 2.25 <0.0001 
Simple Pneumonia 
88 1828 0.05 0.04-0.06 47 1824 0.03 0.02 - 0.04 1.87 1.31 – 2.67 <0.0001 
Severe Pneumonia 10 1828 0.005 0.003 - 0.010 6 1824 0.003 0.001 -  0.007 1.67 0.61 – 4.59 0.31 
Very Severe diseases 
0 1828 0 n/a 0 1824 0 n/a n/a n/a  n/a 
 
x-ray confirmed & non-confirmed 
All Pneumonia 
2134 1826 1.17 1.12 – 1.22 1977 1822 1.08 1.04 – 1.13 1.08 1.01 – 1.14 0.02 
Simple Pneumonia 
1779 1826 0.97 0.93 – 1.02 1645 1822 0.90 0.86 – 0.94 1.08 1.01 – 1.15 0.02 
Severe Pneumonia 
44 1826 0.024 0.017 – 0.032 42 1822 0.023 0.017 – 0.031 1.04 0.68 – 1.59 0.84 
Very Severe diseases 





























# This represents the baseline 25-hydroxvvitamin D levels in the study population 
*** Statistically different between the groups p<0.001 
* Statistically different between the groups p=0.06 




Intervention 25(OH)D serum concentrations 
 








95% CI   
nmol/L 
 




2007 129.5*** (111.1-148.0) 42.9# (38.7-47.0) 
1.5 months after first dose  
n=133 Dec-Jan  
2008 76.3*** (64.5-88.2) 33.0 (28.0-38.0) 
3 months after dose 1 and 
just before dose 2 n=122 
 
 Feb-Mar 
2008 55.5* (46.0-65.0) 39.6 (28.5-50.7) 




2008 104.9*** (89.8-120.0) 52.9 (45.3-60.6) 
4 months after dose 6  
n=101 Jul-Aug 
2009 51.9 (49.0-54.9) 50.1 (45.0-55.1) 
